Mediterranean diet, Mindfulness-Based Stress Reduction and usual care during pregnancy for reducing fetal growth restriction and adverse perinatal outcomes: IMPACT BCN (Improving Mothers for a better PrenAtal Care Trial BarCeloNa): a study protocol for a randomized controlled trial

Francesca Crovetto, Fàtima Crispi, Roger Borras, Cristina Paules, Rosa Casas, Andrés Martín-Asuero, Angela Arranz, Eduard Vieta, Ramon Estruch, Eduard Gratacós, Francesca Crovetto, Fàtima Crispi, Roger Borras, Cristina Paules, Rosa Casas, Andrés Martín-Asuero, Angela Arranz, Eduard Vieta, Ramon Estruch, Eduard Gratacós

Abstract

Background: Fetal growth restriction (FGR) affects 7-10% of all pregnancies resulting in a higher risk of perinatal morbidity and mortality, long-term disabilities, and cognitive impairment. Due to its multifactorial etiology, changes in maternal lifestyle, including suboptimal maternal diet and stress, have increasingly been associated with its prevalence. We present a protocol for the Improving Mothers for a better PrenAtal Care Trial Barcelona (IMPACT BCN), which evaluates two different maternal lifestyle strategies (improved nutrition by promoting Mediterranean diet and stress reduction program based on mindfulness techniques) on perinatal outcomes. The primary objective is to reduce the prevalence of FGR. Secondary aims are to reduce adverse perinatal outcomes and to improve neurodevelopment and cardiovascular profile in children at 2 years of age.

Methods: A randomized parallel, open-blind, single-center trial following a 1:1:1 ratio will select and randomize high-risk singleton pregnancies for FGR (N=1218), according to the criteria of the Royal College of Obstetricians and Gynaecologists (19.0-23.6 weeks' gestation), into three arms: Mediterranean diet, mindfulness-based stress reduction program, and usual care without any intervention. Compliance to the interventions will be randomly tested in 30% of participants with specific biomarkers. Maternal socio-demographic, clinical data, biological samples, and lifestyle questionnaires will be collected at enrollment and at the end of the interventions (34.0-36.6 weeks' gestation), together with a fetoplacental ultrasound and magnetic resonance. Fetoplacental biological samples and perinatal outcomes will be recorded at delivery. Postnatal follow-up is planned up to 2 years of corrected age including neurodevelopmental tests and cardiovascular assessment. Intention-to-treat and population per-protocol analysis will be performed.

Discussion: This is the first randomized study evaluating the impact of maternal lifestyle interventions during pregnancy on perinatal outcomes. The maternal lifestyle interventions (Mediterranean diet and mindfulness-based stress reduction program) are supported by scientific evidence, and their compliance will be evaluated with several biomarkers.

Trial registration: ClinicalTrials.gov NCT03166332 . Registered on April 19, 2017.

Keywords: Fetal growth restriction; Mediterranean diet; Mindfulness-Based Stress Reduction; Perinatal outcome; Pregnancy.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Flow chart of participants in the randomized controlled trial. FGR, fetal growth restriction; RCOG, Royal College of Obstetrics and Gynaecologists; MBSR, mindfulness-based stress reduction; APO, adverse perinatal outcome; PE, preeclampsia

References

    1. Lee ACC, Katz J, Blencowe H, Cousens S, Kozuki N, Vogel JP, et al. National and regional estimates of term and preterm babies born small for gestational age in 138 low-income and middle-income countries in 2010. Lancet Glob Health. 2013;1(1):e26-36. 10.1016/S2214-109X(13)70006-8. Epub 2013 Jun 25. Erratum in: Lancet Glob Health.2013;1(2):e76.
    1. Brosens I, Pijnenborg R, Vercruysse L, Romero R. American Journal of Obstetrics and Gynecology. 2011. The “great obstetrical syndromes” are associated with disorders of deep placentation; pp. 193–201.
    1. Figueras F, Gardosi J. Intrauterine growth restriction: new concepts in antenatal surveillance, diagnosis, and management. Am J Obstet Gynecol. 2011;204:288–300. doi: 10.1016/j.ajog.2010.08.055.
    1. Figueras F, Gratacos E. Update on the diagnosis and classification of fetal growth restriction and proposal of a stage-based management protocol. Fetal Diagn Ther. 2014;36(2):86–98. doi: 10.1159/000357592.
    1. Figueras F, Oros D, Cruz-Martinez R, Padilla N, Hernandez-Andrade E, Botet F, Costas-Moragas C, Gratacos E. Neurobehavior in term, small-for-gestational age infants with normal placental function. Pediatrics. 2009;124(5):e934–e941. doi: 10.1542/peds.2008-3346.
    1. Savchev S, Sanz-Cortes M, Cruz-Martinez R, Arranz A, Botet F, Gratacos E, Figueras F. Neurodevelopmental outcome of full-term small-for-gestational-age infants with normal placental function. Ultrasound Obstet Gynecol. 2013;42(2):201–206. doi: 10.1002/uog.12391.
    1. Sanz-Cortes M, Egaña-Ugrinovic G, Zupan R, Figueras F, Gratacos E. Brainstem and cerebellar differences and their association with neurobehavior in term small-for-gestational-age fetuses assessed by fetal MRI. Am J Obs Gynecol. 2014;210(5):452 e 1–452 e 8. doi: 10.1016/j.ajog.2013.12.008.
    1. Crispi F, Bijnens B, Figueras F, Bartrons J, Eixarch E, Le Noble F, et al. Fetal growth restriction results in remodeled and less efficient hearts in children. Circulation. 2010;121(22):2427–2436. doi: 10.1161/CIRCULATIONAHA.110.937995.
    1. Barker DJP. Fetal origins of coronary heart disease. Bmj. 1995;311(6998):171–174. doi: 10.1136/bmj.311.6998.171.
    1. Timmermans S, Steegers-Theunissen RP, Vujkovic M, Den Breeijen H, Russcher H, Lindemans J, et al. The Mediterranean diet and fetal size parameters: the Generation R Study. Br J Nutr. 2012;108(8):1399–1409. doi: 10.1017/S000711451100691X.
    1. Miranda J, Simões RV, Paules C, Cañueto D, Pardo-Cea MA, García-Martín ML, et al. Metabolic profiling and targeted lipidomics reveals a disturbed lipid profile in mothers and fetuses with intrauterine growth restriction. Sci Rep. 2018;8(1):13614. 10.1038/s41598-018-31832-5.
    1. Chatzi L, Mendez M, Garcia R, Roumeliotaki T, Ibarluzea J, Tardón A, et al. Mediterranean diet adherence during pregnancy and fetal growth: INMA (Spain) and RHEA (Greece) mother-child cohort studies. Br J Nutr. 2012;107(1):135–145. doi: 10.1017/S0007114511002625.
    1. Diego MA, Jones NA, Field T, Hernandez-Reif M, Schanberg S, Kuhn C, et al. Maternal psychological distress, prenatal cortisol, and fetal weight. Psychosom Med. 2006;68(5):747–753. doi: 10.1097/01.psy.0000238212.21598.7b.
    1. Bussières EL, Tarabulsy GM, Pearson J, Tessier R, Forest JC, Giguère Y. Maternal prenatal stress and infant birth weight and gestational age: a meta-analysis of prospective studies. Dev Rev. 2015;36:179–199. doi: 10.1016/j.dr.2015.04.001.
    1. Cusick SE, Georgieff MK. The role of nutrition in brain development: the golden opportunity of the “first 1000 days.”. J Pediatr. 2016;175:16–21. doi: 10.1016/j.jpeds.2016.05.013.
    1. Black RE, Victora CG, Walker SP, Bhutta ZA, Christian P, De Onis M, et al. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet. 2013;382(9890):427–451. doi: 10.1016/S0140-6736(13)60937-X.
    1. Blumfield ML, Hure AJ, MacDonald-Wicks L, Smith R, Collins CE. A systematic review and meta-analysis of micronutrient intakes during pregnancy in developed countries. Nutr Rev. 2013;71:118–132. doi: 10.1111/nure.12003.
    1. Estruch R, Ros E, Salas-Salvadó J, Covas MI, Corella D, Arós F, et al. Primary prevention of cardiovascular disease with a mediterranean diet supplemented with extra-virgin olive oil or nuts. N Engl J Med. 2018;378(25):e34. 10.1056/NEJMoa1800389.
    1. Imhoff-Kunsch B, Briggs V, Goldenberg T, Ramakrishnan U. Effect of n-3 long-chain polyunsaturated fatty acid intake during pregnancy on maternal, infant, and child health outcomes: a systematic review. Paediatr Perinat Epidemiol. 2012;26(SUPPL. 1):91–107. doi: 10.1111/j.1365-3016.2012.01292.x.
    1. Haider BA, Olofin I, Wang M, Spiegelman D, Ezzati M, Fawzi WW. Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis. BMJ. 2013;346:f3443. 10.1136/bmj.f3443.
    1. Aghajafari F, Nagulesapillai T, Ronksley PE, Tough SC, O’Beirne M, Rabi DM. Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational Studies. BMJ. 2013;346:f1169. 10.1136/bmj.f1169.
    1. Buppasiri P, Lumbiganon P, Thinkhamrop J, Ngamjarus C, Laopaiboon M, Medley N. Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes. Cochrane Database Syst Rev. 2015;(2):CD007079. 10.1002/14651858.CD007079.
    1. Grieger JA, Clifton VL. A review of the impact of dietary intakes in human pregnancy on infant birthweight. Nutrients. 2015;7:153–178. doi: 10.3390/nu7010153.
    1. Trichopoulou A, Lagiou P. Healthy traditional Mediterranean diet: an expression of culture, history, and lifestyle. Nutr Rev. 2009;55(11):383–389. doi: 10.1111/j.1753-4887.1997.tb01578.x.
    1. Walsh JM, McGowan CA, Mahony R, Foley ME, McAuliffe FM. Low glycaemic index diet in pregnancy to prevent macrosomia (ROLO study): randomised control trial. World Rev Nutr Diet. 2014;109:101–102. doi: 10.1159/000356110.
    1. Mikkelsen TB, Østerdal ML, Knudsen VK, Haugen M, Meltzer HM, Bakketeig L, et al. Association between a Mediterranean-type diet and risk of preterm birth among Danish women: a prospective cohort study. Acta Obstet Gynecol Scand. 2008;87(3):325–330. doi: 10.1080/00016340801899347.
    1. Economides DL, Nicolaides KH, Linton EA, Perry LA, Chard T. Plasma cortisol and adrenocorticotropin in appropriate and small for gestational age fetuses. Fetal Diagn Ther. 1988;3(3):158–164. doi: 10.1159/000263348.
    1. Welberg LAM, Thrivikraman KV, Plotsky PM. Chronic maternal stress inhibits the capacity to up-regulate placental 11β-hydroxysteroid dehydrogenase type 2 activity. J Endocrinol. 2005;186(3):7–12. doi: 10.1677/joe.1.06374.
    1. Mairesse J, Lesage J, Breton C, Bréant B, Hahn T, Darnaudéry M, Dickson SL, Seckl J, Blondeau B, Vieau D, Maccari S, Viltart O. Maternal stress alters endocrine function of the feto-placental unit in rats. Am J Physiol Endocrinol Metab. 2007;292(6):E1526–E1533. doi: 10.1152/ajpendo.00574.2006.
    1. Glover V, Bergman K, Sarkar P, O’Connor TG. Association between maternal and amniotic fluid cortisol is moderated by maternal anxiety. Psychoneuroendocrinology. 2009;34(3):430–435. doi: 10.1016/j.psyneuen.2008.10.005.
    1. O’Donnell KJ, Bugge Jensen A, Freeman L, Khalife N, O’Connor TG, Glover V. Maternal prenatal anxiety and downregulation of placental 11β-HSD2. Psychoneuroendocrinology. 2012;37(6):818–826. doi: 10.1016/j.psyneuen.2011.09.014.
    1. Romero-Gonzalez B, Caparros-Gonzalez RA, Gonzalez-Perez R, Delgado-Puertas P, Peralta-Ramirez MI. Newborn infants’ hair cortisol levels reflect chronic maternal stress during pregnancy. PLoS One. 2018;13(7):1–13. doi: 10.1371/journal.pone.0200279.
    1. Hofmann SG, Sawyer AT, Witt AA, Oh D. The effect of mindfulness-based therapy on anxiety and depression: a meta-analytic review. J Consult Clin Psychol. 2010;78(2):169–183. doi: 10.1037/a0018555.
    1. Dhillon A, Sparkes E, Duarte RV. Mindfulness-based interventions during pregnancy: a systematic review and meta-analysis. Mindfulness. 2017;8:1421–1437. doi: 10.1007/s12671-017-0726-x.
    1. Nyklíček I, Truijens SEM, Spek V, Pop VJM. Mindfulness skills during pregnancy: prospective associations with mother’s mood and neonatal birth weight. J Psychosom Res. 2018;107:14–19. doi: 10.1016/j.jpsychores.2018.01.012.
    1. Procter SB, Campbell CG. Position of the academy of nutrition and dietetics: nutrition and lifestyle for a healthy pregnancy outcome. J Acad Nutr Diet. 2014;114(7):1099–1103. doi: 10.1016/j.jand.2014.05.005.
    1. Antes G. The new CONSORT statement. BMJ. 2010;340(7748):666.
    1. Royal College of Obstetricians and Gynaecologist The investigation and management of the small for gestational age fetus. Green-top Guidel No 31. 2013;31:1–34.
    1. No authorship indicated Review of full catastrophe living: using the wisdom of your body and mind to face stress, pain, and illness. Contemp Psychol J Rev. 1992;37:609.
    1. Ruffault A, Carette C, Lurbe i Puerto K, Juge N, Beauchet A, Benoliel JJ, Lacorte JM, Fournier JF, Czernichow S, Flahault C. Randomized controlled trial of a 12-month computerized mindfulness-based intervention for obese patients with binge eating disorder: the MindOb study protocol. Contemp Clin Trials. 2016;49:126–133. doi: 10.1016/j.cct.2016.06.012.
    1. Hoge EA, Bui E, Marques L, Metcalf CA, Morris LK, Robinaugh DJ, Worthington JJ, Pollack MH, Simon NM. Randomized controlled trial of mindfulness meditation for generalized anxiety disorder: effects on anxiety and stress reactivity. J Clin Psychiatry. 2013;74(8):786–792. doi: 10.4088/JCP.12m08083.
    1. Marcos J, Renau N, Casals G, Segura J, Ventura R, Pozo OJ. Investigation of endogenous corticosteroids profiles in human urine based on liquid chromatography tandem mass spectrometry. Anal Chim Acta. 2014;812:92–104. 10.1016/j.aca.2013.12.030.
    1. ACOG Practice Bulletin No. 204 Fetal growth restriction. Obstet Gynecol. 2019;133(2):e97–109. doi: 10.1097/AOG.0000000000003070.
    1. Figueras F, Meler E, Iraola A, Eixarch E, Coll O, Figueras J, Francis A, Gratacos E, Gardosi J. Customized birthweight standards for a Spanish population. Eur J Obstet Gynecol Reprod Biol. 2008;136(1):20–24. doi: 10.1016/j.ejogrb.2006.12.015.
    1. Spielberger, CD. State Trait Anxiety Inventory. In: I.B. Weiner and W.E. Craighead, editors. The Corsini Encyclopedia of Psychology. 2010.
    1. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24(4):385–396. doi: 10.2307/2136404.
    1. Bech P, Olsen LR, Kjoller M, Rasmussen NK. Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 mental health subscale and the WHO-five well-being scale. Int J Methods Psychiatr Res. 2003;12(2):85–91. doi: 10.1002/mpr.145.
    1. Baer RA, Smith GT, Hopkins J, Krietemeyer J, Toney L. Using self-report assessment methods to explore facets of mindfulness. Assessment. 2006;13(1):27–45. doi: 10.1177/1073191105283504.
    1. Mindell JA, Cook RA, Nikolovski J. Sleep patterns and sleep disturbances across pregnancy. Sleep Med. 2015;16(4):483–488. doi: 10.1016/j.sleep.2014.12.006.
    1. Aydlett L. Neonatal Behavioral Assessment Scale (NBAS). In: Goldstein S., Naglieri J.A. editors. Encyclopedia of Child Behavior and Development. Boston: Springer; 2011. 10.1007/978-0-387-79061-9_425.
    1. Squires J, Twombly E, Bricker D, Potter L. ASQ-3 User’s Guide [Internet] 2009. Ages and Stages Questionnaires- third edition; pp. 3–6.
    1. Viezel K, Zibulsky J, Dumont R, Willis JO. Encyclopedia of Special Education. 2014. Bayley scales of infant and toddler development, third edition.
    1. CPMP/ICH/363/96. ICH E9 statistical principles for clinical trials. URL: , last access: 12 Jan 2018.
    1. CPMP/EWP/1776/99 Rev1. Guideline on missing data in confirmatory trials. URL:, last access: 21 Apr 2013.
    1. Verbeke G, Molenberghs G. Linear mixed models for longitudinal data. New York: Springer-Verlag; 2000.
    1. Brown H, Prescott R. Applied mixed models in medicine. New York: Wiley; 1999.
    1. Molenberghs G, Kenward MG. Missing data in clinical studies. Chichester, West Susex: Wiley; 2007.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner